Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expression

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 5, 2011, Pages 1377-1382

  Unger, Keith R ^a   Romney, Davis A ^a   Koc, Mehmet ^a,c   Moskaluk, Christopher A ^b   Friel, Charles M ^b   Foley, E F ^b   Rich, Tyvin A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SELCUK UNIVERSITY   (Turkey)

Author keywords

Chronomodulated chemoradiation; Rectal cancer; Thymidine phosphorylase; Thymidylate synthase

Indexed keywords

CAPECITABINE; CELECOXIB; CHEMORADIATION; LOCAL FAILURE; PATHOLOGIC COMPLETE RESPONSE (PCR); PELVIC CONTROLS; POST TREATMENT; PREOPERATIVE CHEMORADIATION; RECTAL ADENOCARCINOMA; RECTAL CANCER; SURGICAL RESECTION; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; TREATMENT BREAK; TUMOR REGRESSION; X-RADIATION;

PATHOLOGY; PHOSPHORYLATION; RADIOTHERAPY; SURGERY; TOXICITY; TUMORS;

DISEASES;

CAPECITABINE; CELECOXIB; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ANUS SPHINCTER; ANUS SURGERY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; DIARRHEA; ERECTILE DYSFUNCTION; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; MALE; NAUSEA AND VOMITING; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROCTITIS; PROTEIN EXPRESSION; RADIATION DERMATITIS; RECTOVAGINAL FISTULA; RECTUM CARCINOMA; RECTUM STENOSIS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT RESPONSE; UTERUS SARCOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; RECTAL NEOPLASMS; SULFONAMIDES; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79960100500     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.016     Document Type: Article

References (26)

1. C.C. Boring, T.S. Squires, and T. Tong Cancer statistics, 1993 CA Cancer J Clin 43 1 1993 7 26 (Pubitemid 23049040)
2. Improved survival with preoperative radiotherapy in resectable rectal cancer Swedish Rectal Cancer Trial N Engl J Med 336 14 1997 980 987
3. R. Sauer, H. Becker, W. Hohenberger, C. Rödel, C. Wittekind, R. Fietkau, P. Martus, J. Tschmelitsch, E. Hager, C.F. Hess, J.H. Karstens, and T. Liersch Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 17 2004 1731 1740
4. J.C. Kim, T.W. Kim, J.H. Kim, C.S. Yu, H.C. Kim, and H.M. Chang Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 63 2 2005 346 353 (Pubitemid 41317150)
5. R. Yerushalmi, E. Idelevich, Y. Dror, S.M. Stemmer, A. Figer, and A. Sulkes Preoperative chemo-radiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil J Surg Oncol 93 7 2006 529 533 (Pubitemid 43806987)
6. M. Miwa, M. Ura, M. Nishida, N. Sawada, T. Ishikawa, and K. Mori Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 8 1998 1274 1281 (Pubitemid 28342121)
7. N. Sawada, T. Ishikawa, F. Sekiguchi, Y. Tanaka, and H. Ishitsuka X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine in human xenografts Clin Cancer Res 5 1999 2948 2953 (Pubitemid 29493974)
8. N. Sawada, T. Ishikawa, Y. Fukase, M. Nishida, T. Yoshikubo, and H. Ishitsuka Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts Clin Cancer Res 4 4 1998 1013 1019 (Pubitemid 28183404)
9. T.A. Rich, and R. Shepard COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: Esophagus, stomach, and pancreas Am J Clin Oncol 26 4 2003 S110 S113
10. O. Dworak, L. Keilholz, and A. Hoffmann Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1 1997 19 23 (Pubitemid 27138353)
11. E. Lin, J.S. Morris, and G.D. Ayers Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity Oncology (Williston Park) 2002 16(12) (Suppl 14):31-37
12. F.M. Smith, J.V. Reynolds, E.W. Kay, P. Crotty, J.O. Murphy, and D. Hollywood COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy Int J Radiat Oncol Biol Phys 64 2 2006 466 472 (Pubitemid 43083434)
13. E.H. Lin, S.A. Curley, C.C. Crane, B. Feig, J. Skibber, and M. Delcos Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer Am J Clinical Oncology 29 3 2006 232 239
14. J.C. Kim, T.W. Kim, J.H. Kim, C.S. Yu, H.C. Kim, and H.M. Chang Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 63 2 2005 346 353 (Pubitemid 41317150)
15. R. Yerushalmi, E. Idelevich, Y. Dror, S.M. Stemmer, A. Figer, and A. Sulkes Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil J Surg Oncol 93 7 2006 529 533 (Pubitemid 43806987)
16. D.M. Hyams, E.P. Mamounas, N. Petrelli, H. Rockette, J. Jones, and H.S. Wieand A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project protocol R-03 Dis Colon Rectum 40 2 1997 131 139 (Pubitemid 27074280)
17. C. Jakob, T. Liersch, W. Meyer, G.B. Baretton, P. Häusler, and W. Schwabe Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy Am J Surg Pathol 29 10 2005 1304 1309 (Pubitemid 41368765)
18. T. Liersch, C. Langer, B.M. Ghadimi, B. Kulle, D.E. Aust, and G.B. Baretton Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy J Clin Oncol 24 25 2006 4062 4068 (Pubitemid 46628475)
19. S. Popat, A. Matakidou, and R.S. Houlston Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis J Clin Oncol 22 3 2004 529 536 (Pubitemid 41079782)
20. D. Edler, M. Hallström, P.G. Johnston, I. Magnusson, P. Ragnhammar, and H. Blomgren Thymidylate synthase expression: An independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer Clin Cancer Res 6 4 2000 1378 1384 (Pubitemid 30226223)
21. C.G. Leichman, H.J. Lenz, L. Leichman, K. Danenberg, J. Baranda, and S. Groshen Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin J Clin Oncol 15 10 1997 3223 3229 (Pubitemid 27419335)
22. R. Metzger, K. Danenberg, C.G. Leichman, D. Salonga, E.L. Schwartz, and S. Wadler High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil Clin Cancer Res 4 10 1998 2371 2376 (Pubitemid 28477901)
23. C. Jakob, D.E. Aust, W. Meyer, G.B. Baretton, W. Schwabe, and P. Häusler Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumor regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer J Pathol 204 5 2004 562 568 (Pubitemid 39585955)
24. J. Stoehlmacher, E. Goekkurt, U. Mogck, D.E. Aust, M. Kramer, and G.B. Baretton Thymidylate synthase genotypes and tumor regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation Cancer Lett 272 2 2008 221 225
25. C. Blanquicett, M.W. Saif, D.J. Buchsbaum, M. Eloubeidi, S.M. Vickers, and D.C. Chhieng Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: Clinical implications of abscopal effects Clin Cancer Res 11 2005 (24)(Pt 1):8773-8781.
26. Angelita Habr-Gama. Personal communication, 2010.